Jul 12, 2018
This episode features Professor David Currow (University of
Technology Sydney, Ultimo, NSW, Australia. Wolfson Palliative Care
Research Centre, University of Hull, Hull, UK). This
transnational online survey aimed to determine the impact of a
phase III randomised controlled trial on palliative care
clinicians’ self-reported practice change. The orginal study
in question described the use of octreotide in the
management of inoperable malignant bowel obstruction. This survey
was distributed in 2016, 2 years after the first publication of the
study in a peer-reviewed journal.The results demonstrated that
out of 106 respondents, 52 (49.1%) indicated modified practice
(60.9% of those who had previously prescribed octreotide in this
setting). In those who reported practice change, most
frequently octreotide was now used when other therapies failed. The
results suggest that there is a cohort of ‘early
adopters’ within palliative care practice as new evidence
becomes available.
Full paper available from: http://journals.sagepub.com/doi/abs/10.1177/0269216318778460?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
If you would like to record a podcast about your published (or
accepted) Palliative Medicine paper, please contact Dr Amara Nwosu:
anwosu@liverpool.ac.uk